Compare GPMT & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | BSX |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.8M | 137.8B |
| IPO Year | 2017 | 1992 |
| Metric | GPMT | BSX |
|---|---|---|
| Price | $2.37 | $94.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 17 |
| Target Price | $3.13 | ★ $125.88 |
| AVG Volume (30 Days) | 210.0K | ★ 9.3M |
| Earning Date | 02-12-2026 | 02-04-2026 |
| Dividend Yield | ★ 8.44% | N/A |
| EPS Growth | N/A | ★ 54.68 |
| EPS | N/A | ★ 1.87 |
| Revenue | N/A | ★ $19,349,000,000.00 |
| Revenue This Year | N/A | $21.05 |
| Revenue Next Year | $21.74 | $11.44 |
| P/E Ratio | ★ N/A | $50.65 |
| Revenue Growth | N/A | ★ 21.61 |
| 52 Week Low | $1.61 | $85.98 |
| 52 Week High | $3.19 | $109.50 |
| Indicator | GPMT | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 31.72 | 42.88 |
| Support Level | $2.41 | $95.55 |
| Resistance Level | $2.49 | $96.33 |
| Average True Range (ATR) | 0.09 | 1.45 |
| MACD | -0.01 | 0.23 |
| Stochastic Oscillator | 9.23 | 62.92 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.